You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Head and neck cancers

Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck

  • Technology appraisal guidance
  • Reference number: TA145
  • Published:  25 June 2008
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Head and neck cancer - cetuximab: Appeal documents

An appeal hearing was held on Wednesday 22nd August 2007. The Institute awaits the decision of the appeal panel.

  • Merck Serono

  • Mouth Cancer Foundation

  • Royal College of Radiologists


This page was last updated: 30 March 2010

Back to top